FR2358402B1 - - Google Patents

Info

Publication number
FR2358402B1
FR2358402B1 FR7721149A FR7721149A FR2358402B1 FR 2358402 B1 FR2358402 B1 FR 2358402B1 FR 7721149 A FR7721149 A FR 7721149A FR 7721149 A FR7721149 A FR 7721149A FR 2358402 B1 FR2358402 B1 FR 2358402B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7721149A
Other languages
French (fr)
Other versions
FR2358402A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2358402A1 publication Critical patent/FR2358402A1/fr
Application granted granted Critical
Publication of FR2358402B1 publication Critical patent/FR2358402B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/19—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FR7721149A 1976-07-12 1977-07-08 Acides 2-(3-(2-thiazolylthio)phenyl)alcanoiques utiles comme medicaments et procede de preparation Granted FR2358402A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70486376A 1976-07-12 1976-07-12

Publications (2)

Publication Number Publication Date
FR2358402A1 FR2358402A1 (fr) 1978-02-10
FR2358402B1 true FR2358402B1 (enExample) 1980-02-29

Family

ID=24831153

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7721149A Granted FR2358402A1 (fr) 1976-07-12 1977-07-08 Acides 2-(3-(2-thiazolylthio)phenyl)alcanoiques utiles comme medicaments et procede de preparation

Country Status (7)

Country Link
JP (1) JPS539765A (enExample)
DE (1) DE2731292A1 (enExample)
DK (1) DK287977A (enExample)
FR (1) FR2358402A1 (enExample)
GB (1) GB1543276A (enExample)
NL (1) NL7707161A (enExample)
SE (1) SE7707451L (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10224463A1 (de) 2002-06-03 2003-12-11 Bayer Ag Verfahren zur Herstellung von 5-Nitro-3,4-dihydro-1(2H)-naphthalinon, 1,5-Naphthalindiamin und 1,5-Naphthalindiisocyanat
CA2938571C (en) 2014-02-03 2020-12-22 Quadriga Biosciences, Inc. Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
BR112016017993A2 (pt) 2014-02-03 2017-08-08 Quadriga Biosciences Inc Gama-aminoácidos beta-substituídos e análogos como agentes quimioterapêuticos
US9783487B2 (en) 2015-08-03 2017-10-10 Quadriga Biosciences, Inc. Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890337A (en) * 1973-11-23 1975-06-17 Lilly Co Eli {60 ,{60 ,{60 -Trifluoro-2-nitro-6-{8 oxa(thia)zolyl{9 thio-p-tolunitriles

Also Published As

Publication number Publication date
FR2358402A1 (fr) 1978-02-10
SE7707451L (sv) 1978-01-13
JPS539765A (en) 1978-01-28
GB1543276A (en) 1979-03-28
DE2731292A1 (de) 1978-01-19
NL7707161A (nl) 1978-01-16
DK287977A (da) 1978-01-13

Similar Documents

Publication Publication Date Title
FR2358770B1 (enExample)
DE2637541C2 (enExample)
JPS5372304U (enExample)
FR2358402B1 (enExample)
JPS5338926U (enExample)
JPS5370056U (enExample)
JPS5623169Y2 (enExample)
JPS5650148Y2 (enExample)
FR2346866B1 (enExample)
JPS5363231U (enExample)
JPS52151604U (enExample)
JPS52149811U (enExample)
JPS52130112U (enExample)
JPS52129829U (enExample)
CS175521B1 (enExample)
DD125369A1 (enExample)
DD124413A1 (enExample)
DD127608A1 (enExample)
DD127510A1 (enExample)
DD127374A1 (enExample)
DD126287A1 (enExample)
DD126040A1 (enExample)
DD125616A1 (enExample)
DD125535A1 (enExample)
DD126052A1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse